Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Avid Bioservices
Sort By
Newest First
1 / 2
1 / 2
Viral Vectors
A Viral Vector CDMO Vision that Resonates
Drew Brennan; Chris Berger; Elie Hanania, Ph.D.; Dave Ingamells; Rami Barghout, PE
Avid Bioservices
PAO-03-24-CL-06
Mar 14, 2024
Viral Vector Manufacturing
Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control
Chris Berger; Kilian Witzel
Avid Bioservices
PAO-02-23-CL-03
Mar 14, 2023
Scale-Up
Scale-Up Expertise to Support Your Biologics Life Cycle
Pramthesh (Prem) Patel, Ph.D.
Avid Bioservices
PAO-02-23-CL-06
Mar 02, 2023
PLIs
A Strategic Approach to Pre-License Inspections
William Leonardi, Ph.D.
Avid Bioservices
PAO-11-022-CL-03
Dec 15, 2022
Viral Vectors
Risk-Based Optimization of Viral Vector Processes Adds Real Value
Elie Hanania, Ph.D.; Tatiana Mello, M.S.
Avid Bioservices
PAO-09-022-CL-05
Oct 25, 2022
Viral Vector Manufacturing
Avid Bioservices, Inc. and CRB Highlight Efforts that Enabled Opening of First Phase of New Viral Vector Facility in California in Only Eight Months
Avid Bioservices
PR-M06-22-05
Jun 16, 2022
Capacity Expansion
Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business
Avid Bioservices
PR-M06-22-02
Jun 13, 2022
Board of Directors
Driving the Industry Forward on Multiple Boards
Jeanne Thoma
Avid Bioservices
PAO-06-22-R250-01
Jun 01, 2022
Viral Vector Manufacturing
Approaching Viral Vector Manufacturing With an Emphasis on Quality and Design
Chris Berger; Atef Khezri
Avid Bioservices
PAO-05-022-CL-02
May 10, 2022
Biologics CDMO
Growing as a Trusted, Dedicated Commercial Biologics CDMO
Nicholas Green
Avid Bioservices
PAO-01-22-R250-02
Jan 26, 2022
2021 Roundup: The Year of Cell and Gene Therapy
David Alvaro, Ph.D.
Pharma's Almanac
PA734
Dec 20, 2021
Process Development
Shortening Biopharmaceutical Process Development Timelines with High-Throughput Approaches.
Jeanette Doerr, Ph.D.; Haiou Yang, Ph.D.
Avid Bioservices
PAO-11-21-CL-02
Nov 09, 2021
Gene Therapy
A Customer-Centric Approach to Cell and Gene Therapy Manufacturing
Drew Brennan
Avid Bioservices
PAO-10-21-CL-06
Oct 13, 2021
Facility Expansion
Expanding and Serving the Market with Flexible Single-Use Capacity
Michael Alston, Jr.
Avid Bioservices
PAO-09-21-CL-09
Sep 17, 2021
Quality
Strong Quality Systems and Quality Culture Ensure Inspection-Ready Status
Ray Marzouk
Avid Bioservices
PAO-06-21-CL-12
Jun 29, 2021
Strategic Growth
Unique Commercial Experience Primes Avid Bioservices for Growth
Nicholas Green
Avid Bioservices
PAO-05-21-CL-03
May 12, 2021
Biosimilars
Successful Biosimilar Development Requires an Outsourcing Partner with the Right Experience
Richard Richieri
Avid Bioservices
PAO-03-21-CL-03
Mar 18, 2021
Single-Use Technology
Stainless Steel to Single-Use: How to Adapt to the Changing Landscape in SUT
Ryan MacDonald
Avid Bioservices
PAP-Q4-20-CL-004
Dec 09, 2020
Leadership
A CEO’s Perspective: Positioning a CDMO for Significant Growth
Nicholas Green
Avid Bioservices
PAP-Q3-20-CL-008
Sep 29, 2020
Industry Leader Insight
Accelerating COVID-19 Programs with Comprehensive Support from Cell Line to Commercial Production at a Single Site
Magnus Schroeder, Ph.D.
Avid Bioservices
PAP-Q2-20-CL-002
Jul 01, 2020
